EMJ 3.2 has entered the building! This truly multidisciplinary eJournal returns for its 10th issue and its second of 2018. EMJ 3.2 includes a plethora of high-quality peer-reviewed articles that detail a myriad of fascinating topics across seven therapeutic areas: urology, haematology, oncology, gastroenterology, hepatology, neurology, and reproductive health. This eJournal must not be missed.
Late-Breaking Abstracts: Health Status Benefits of Mavacamten in Obstructive Hypertrophic Cardiomyopathy and the Modifying Effect of Ejection Fraction on the Therapeutic Benefit of Omecamtiv Mecarbil in Heart Failure